US 11801298
MERS-CoV vaccine
granted A61KA61K2039/53A61K39/12
Quick answer
US patent 11801298 (MERS-CoV vaccine) held by Inovio Pharmaceuticals, Inc. expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/53, A61K39/12, A61K39/215, A61P